LillyDirect GLP-1 pricing
As of August 31, 2026:
LillyDirect does not publish a compounded injectable price; its published pricing is tirzepatide as a brand-name vial at $299 per month at the starting dose, rising to $449 at higher doses (verified August 25, 2026, grade B). Full terms and modeled annual costs are in the table below.
- Provider ID
- prv_lillydirect
- Canonical name
- LillyDirect
- Also known as
- —
- Official domain
- lillydirect.lilly.com
- Provider type
- manufacturer direct
- Pricing model
- brand direct
- Membership fee
- none
- Dose pricing
- increasing
- Shipping
- included
- Consultation
- paid
- Price lock stated
- not stated
- Commitment
- month-to-month
- Cancellation
- No subscription; order per fill
- Pharmacies (provider-stated)
- Lilly-contracted mail-order pharmacy
- Pharmacy classification (provider-stated)
- brand
- States served
- all-50
- Affiliate relationship with this site
- none recorded
- Record last verified
- August 25, 2026
Every published plan
| Medication | Formulation | Plan | Advertised /mo | Maintenance-dose /mo | All-in /mo | 12-month all-in | Grade | Verified | Source |
|---|---|---|---|---|---|---|---|---|---|
| tirzepatide | brand-name vial | month-to-month | $299 | $449 | $449 | $4,938 | B | zepbound.lilly.com |
Notes from verification
- tirzepatide, month-to-month: Self-pay Zepbound vials: $299 at 2.5 mg (initiation dose), $399 at 5 mg, $449 at 7.5 to 15 mg under the Self Pay Journey offer when refill-timing requirements are met; regular prices if conditions are missed are $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. Card terms stated through December 31, 2026.
Price history
| Date | Medication | What | Previous | New | Type | Source |
|---|---|---|---|---|---|---|
| November 6, 2025 | tirzepatide | Zepbound vials (2.5 mg / 5 mg / 7.5–15 mg, Self Pay Journey) | $349 / $499 / $499 | $299 / $399 / $449 | provider price change | Lilly coverage and savings page; verified 2026-08-25. |
| February 25, 2025 | tirzepatide | Zepbound vials (2.5 mg / 5 mg; 7.5 and 10 mg added) | $399 / $549 | $349 / $499; $499 higher doses | provider price change | Eli Lilly announcement. |
| August 27, 2024 | tirzepatide | Zepbound vials (2.5 mg / 5 mg) | — | $399 / $549 | provider price change | Eli Lilly announcement. |
Regulatory records
None on file for LillyDirect. Per the regulatory policy, only events matched to a primary source are published.
First-party price sources
- https://zepbound.lilly.com/hcp/coverage-savings — recorded August 25, 2026
Data
This record as JSON: /providers/lillydirect/data.json · API: /api/v1/providers/lillydirect.json · Cite as “GLP-1 Price Compare, LillyDirect Pricing, verified August 25, 2026”. Wrong? File a correction.
Questions this page answers
How much does LillyDirect cost?
LillyDirect does not publish a compounded injectable price; its published pricing is tirzepatide as a brand-name vial at $299 per month at the starting dose, rising to $449 at higher doses (verified August 25, 2026, grade B). Full terms and modeled annual costs are in the table below.